Press Releases

BioIVT Supports COVID-19 Drug, Diagnostic and Vaccine Researchers by Expanding its Inventory of Patient Plasma, Serum and Saliva Specimens

Specimens can be used to validate SARS-CoV-2 in-vitro diagnostics, develop new drugs and vaccines, and investigate the impact of co-morbidities and social demographics on disease progression

Michael Gibertini Joins Elligo as Chief Development Officer

Elligo Health Research is proud to welcome Michael Gibertini, Ph.D., to its leadership team. Gibertini joins the team at the healthcare-enabling company as the new chief development officer and will develop new lines of business to support Elligo’s mission to bring clinical research as a care option to patients.

CluePoints Launches Powerful Business Intelligence Platform

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the launch of its new business intelligence platform, BEYOND. Designed to encompass more than just early risk detection, this extended visualization solution takes CluePoints beyond the interrogation of data and allows Sponsor and CRO users to explore areas of interest in one integrated business intelligence system.

snapIoT Announces AI-Powered Automated IRB Packaging and UAT Reporting for Patient Engagement Solutions

snapIoT announces a new feature for it's snapClinical platform - IRB Packaging and UAT Reporting. This feature was designed to automate and expedite the submission process of patient engagement solutions for IRB and ethics approvals which allows Pharmas and CROs to quickly deploy decentralized trials in a faster and more reliable manner.

Intermediates for API about Flu Treatment Are Now Available at Alfa Chemistry

Intermediates for API about Flu Treatment Are Now Available at Alfa Chemistry

AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

Broad-spectrum Antiviral Drug Discovery Services Are Ready to Facilitate SARS-CoV-2 Research

Creative Biolabs has combined with integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in SARS-CoV-2 candidates screening, effective viral inhibitors discovery, therapeutic antibody development and vaccine exploration.

CD Genomics Upgrades Highly Accurate Single-Cell Sequencing Services for Genome Researchers and Projects

Creative Enzymes Launches Enzymes for Coronavirus Nucleic Acid Test to Help the Detection of COVID-19

TARA biosystems demonstrates in vitro cardiac biology model mimics human drug response

Boehringer Ingelheim Extends TrialScope Partnership

A customer since 2015, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five years.

TrialScope Expands Leadership Team with New Chief Commercial Officer

TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive team.

CD Genomics Releases Kits and Reagents for Coronavirus Research to Aid in COVID-19 Response

Creative Proteomics Launches Several Newly-developed Services for Protein Related Projects

Creative Enzymes Introduces Newly-Developed Enzyme Products for Some Related Projects

Creative BioMart Enlarged Its Metabolism Proteins List

Profacgen Provides Pharmacophore Modeling for Drug Design

Creative Biostructure Updated Its Membrane Protein Service

Lifeasible Updated Its Physical Purity Testing Service for Seed Testing

Matexcel Updated Its Customized Polymerization Service